z-logo
open-access-imgOpen Access
Fusobacterium nucleatum Pleural Empyema in a Patient with Progressive Rheumatoid Arthritis and Immunosuppression
Author(s) -
Wesley Tang,
Zi Yu Liu,
Charles M. Abreu
Publication year - 2021
Publication title -
case reports in infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2090-6625
pISSN - 2090-6633
DOI - 10.1155/2021/5212401
Subject(s) - medicine , fusobacterium nucleatum , rheumatoid arthritis , empyema , pneumonia , pleural effusion , levofloxacin , amoxicillin , immunosuppression , gastroenterology , surgery , antibiotics , periodontitis , porphyromonas gingivalis , microbiology and biotechnology , biology
Fusobacterium nucleatum is an anaerobic oral commensal organism that is often associated with inflammatory bowel disease, adverse pregnancy outcomes, respiratory tract infections, and Lemierre's syndrome. Rheumatoid arthritis is often associated with pleuropulmonary manifestations including noninfectious pleural effusions and interstitial lung disease. We present a case of a 47-year-old man with progressive rheumatoid arthritis on immunosuppressive therapy who was found to have a left-sided pleural effusion, thought secondary to possible pneumonia, and was treated with levofloxacin and methylprednisolone. He presented a month later and was found to have a large left-sided thick-walled fluid collection found to be an empyema. A chest tube was placed, and fluid culture grew Fusobacterium nucleatum . The patient was successfully treated with intrapleural fibrinolytic therapy and amoxicillin-clavulanic acid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom